Non-Surgical Debridement

Closed Pre-Solicitation Posted

Solicitation number
BARDA-CBRN-11122024-VES
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Washington, District of Columbia 20024, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services (HHS), is issuing a Sources Sought Notice to collect information on FDA approved enzymatic debridement products for the non-surgical removal of necrotic tissue from severe burns. BARDA is interested in products that can function in non-surgical settings, achieve complete debridement within 24 hours, and have the potential to support a vendor-managed inventory for emergency distribution. The notice requests technical details on product performance, use cases, and manufacturing/distribution capabilities, as well as business information including company background, pricing, and market penetration strategies. Responses are due by December 2, 2024, and will inform potential future solicitation opportunities in support of BARDA's mission to build national preparedness for medical countermeasures.

This notice has no set-aside designation, so both Other than Small Businesses and Small Businesses are eligible to respond. The notice does not mention any potential incumbents or current contractors. It also does not provide any specific award values or budget ranges, nor does it specify a quantity of goods or timeline for services.

Notice text

PURPOSE

The Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS), is issuing this Sources Sought Notice (SSN) to collect information on specific product and service suppliers supporting the mission. Information collected from this SSN serves as market research whereby BARDA could partner with one or more organizations to achieve the preparedness goals set forth by the U.S. Government (USG). The information collected in response to this SSN is intended to strengthen BARDA’s understanding of the current and future marketplace. This notice seeks information from Other than Small Businesses (OTSB) and Small Businesses (SB) regarding their qualifications, experience, and capabilities.

BARDA’s mission is primarily to build national preparedness by developing a broad range of medical countermeasures (MCM) which mitigate medical consequences from various threats.  Under this SSN, BARDA is specifically seeking information on FDA approved, enzymatic debridement products for non-surgical removal of necrotic eschar tissue from severe burns or those that may be approved in the next 2 years. The technologies sought are expected to function in U.S. burn centers. Burn debridement products that can be well-integrated into routine burn care settings inherently build national preparedness by creating the capability to use these tools during mass casualties involving burn injuries. (See Objective section below for details).

Files

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity